Literature DB >> 32705293

Acute life-threatening toxicity from CAR T-cell therapy.

Elie Azoulay1, Michael Darmon2, Sandrine Valade2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32705293     DOI： 10.1007/s00134-020-06193-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

Review 1.  Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.

Authors:  Moritz Ernst; Annika Oeser; Burcu Besiroglu; Julia Caro-Valenzuela; Mohamed Abd El Aziz; Ina Monsef; Peter Borchmann; Lise J Estcourt; Nicole Skoetz; Marius Goldkuhle
Journal:  Cochrane Database Syst Rev       Date:  2021-09-13

Review 2.  Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement.

Authors:  Matteo Di Nardo; Ali H Ahmad; Pietro Merli; Matthew S Zinter; Leslie E Lehman; Courtney M Rowan; Marie E Steiner; Sangeeta Hingorani; Joseph R Angelo; Hisham Abdel-Azim; Sajad J Khazal; Basirat Shoberu; Jennifer McArthur; Rajinder Bajwa; Saad Ghafoor; Samir H Shah; Hitesh Sandhu; Karen Moody; Brandon D Brown; Maria E Mireles; Diana Steppan; Taylor Olson; Lakshmi Raman; Brian Bridges; Christine N Duncan; Sung Won Choi; Rita Swinford; Matt Paden; James D Fortenberry; Giles Peek; Pierre Tissieres; Daniele De Luca; Franco Locatelli; Selim Corbacioglu; Martin Kneyber; Alessio Franceschini; Simon Nadel; Matthias Kumpf; Alessandra Loreti; Roelie Wösten-Van Asperen; Orsola Gawronski; Joe Brierley; Graeme MacLaren; Kris M Mahadeo
Journal:  Lancet Child Adolesc Health       Date:  2021-12-09

Review 3.  Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies.

Authors:  Wen-Ying Lin; Hsin-Hui Wang; Yi-Wei Chen; Chun-Fu Lin; Hueng-Chuen Fan; Yi-Yen Lee
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

Review 4.  Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects.

Authors:  Reza Elahi; Amir Hossein Heidary; Kaveh Hadiloo; Abdolreza Esmaeilzadeh
Journal:  Stem Cell Rev Rep       Date:  2021-09-02       Impact factor: 6.692

Review 5.  Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.

Authors:  Ya Zhang; Xin Wang; Zixun Yin
Journal:  Biomark Res       Date:  2021-07-13

6.  Neurological updates: neurological complications of CAR-T therapy.

Authors:  Emma C Tallantyre; Nia A Evans; Jack Parry-Jones; Matt P G Morgan; Ceri H Jones; Wendy Ingram
Journal:  J Neurol       Date:  2020-11-02       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.